BRIEF-MPJS Group Ltd Files For U.S. IPO - Filing-March 2024-www.financetom.com

BRIEF-MPJS Group Ltd Files For U.S. IPO - Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-MPJS Group Ltd Files For U.S. IPO - Filing

May 25, 2025 11:01 PM

April 30 (Reuters) -

* MPJS GROUP LTD: FILES FOR U.S. IPO - FILING

* MPJS GROUP LTD - OFFERING PRICE EXPECTED BETWEEN $4.00 AND

$5.00

PER SHARE - SEC FILING

* MPJS GROUP LTD: FILES FOR IPO OF UP TO 1.5 MILLION

ORDINARY

* MPJS GROUP LTD: REVERE SECURITIES LLC IS UNDERWRITER TO

IPO

* MPJS : HAVE APPLIED TO LIST ORDINARY SHARES ON THE

NASDAQ

CAPITAL MARKET UNDER SYMBOL "MPJS"

Source text:

Previous page： What's Going On With Semler Scientific Stock Monday? Next page： Quikrete to take Summit Materials private in deal valued at $11.5 bln

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

What's Going On With Semler Scientific Stock Monday?

Nov 25, 2024

Semler Scientific Inc ( SMLR ) shares are trading higher Monday. The company launched an offering and provided an update on its Bitcoin (CRYPTO: BTC) holdings. What Happened: Semler Scientific ( SMLR ) announced that it acquired 297 Bitcoin for $29.1 million in cash between Nov. 18 and Nov. 22. The company made the purchases at an average price of...

Quikrete to take Summit Materials private in deal valued at $11.5 bln

Nov 25, 2024

By Aatreyee Dasgupta and Kannaki Deka Nov 25 (Reuters) - Summit Materials ( SUM ) said on Monday rival Quikrete would acquire the company in a cash deal valued at $11.5 billion, in a move to capitalize on higher demand for building materials. The sector's deal-making activity has been heating up due to rising U.S. government infrastructure spending and anticipation...

Cassava Sciences' Controversial Alzheimer's Drug Fails To Hit Primary Goal In Pivotal Study, Halts Late-Stage Studies

Nov 25, 2024

On Monday, Cassava Sciences Inc. ( SAVA ) stock plunged after the company released topline data from the Phase 3 ReThink-ALZ study of simufilam in mild-to-moderate Alzheimer’s disease. The trial did not meet the pre-specified co-primary, secondary, and exploratory biomarker endpoints. In July, CEO Rick Barry wrote a letter to shareholders and employees, saying that the company is in the final...

KULR Gets US Navy Contract to Develop Technology for Battery Safety

Nov 25, 2024

09:28 AM EST, 11/25/2024 (MT Newswires) -- KULR Technology ( KULR ) said Monday it has been awarded a contract by the US Navy to develop high-temperature internal short circuit cells for improved battery safety in critical applications. The project will support a wide range of uses, particularly in the aviation sector, by allowing the simulation of extreme conditions to...